Liver Cirrhosis

Think of your liver as a busy, hardworking organ that never really gets a day off. Every minute, it is filtering your blood, producing proteins, processing nutrients, breaking down medications, and clearing toxins. When something damages liver cells whether that is alcohol, a virus, or fat accumulation the liver tries to fix itself.

In the short term, that self-repair works. But when the damage keeps coming, month after month and year after year, the repair process goes wrong. Instead of rebuilding healthy liver tissue, the liver lays down scar tissue tough, fibrous material that cannot do any of the liver's essential jobs.

That is cirrhosis. A liver so scarred that large portions of it have stopped functioning properly.

Cirrhosis of the liver is permanent. Unlike earlier stages of liver damage which can fully reverse with the right treatment the scarring of established cirrhosis cannot be undone. But that does not mean nothing can be done. Far from it. The right treatment can stop further scarring, manage complications, and in some cases partially reverse early cirrhosis. Many people live for a decade or more after diagnosis with a good quality of life.

A healthy liver performs over 500 functions every single day. When cirrhosis takes hold, all of those functions are gradually compromised. Here is what that looks like in practice.

Toxins build up in the blood. Normally, the liver converts ammonia — a waste product of protein metabolism — into urea, which the kidneys excrete. A cirrhotic liver cannot do this efficiently. Ammonia accumulates and begins to affect the brain, causing confusion, forgetfulness, and in severe cases, loss of consciousness. This is called hepatic encephalopathy.

Fluid leaks into the wrong places. The liver produces albumin — the protein that keeps fluid inside blood vessels. When albumin production falls, fluid leaks out into the abdomen (causing swelling called ascites) and into the legs (causing ankle and leg oedema).

Blood clotting becomes impaired. The liver makes the proteins your blood needs to clot properly. When it cannot produce enough of them, even minor cuts bleed longer, and the risk of serious internal bleeding rises.

Blood pressure in the portal vein rises. Scar tissue blocks the normal flow of blood through the liver, causing pressure to build up in the large vein that carries blood from the digestive organs to the liver. This portal hypertension forces blood to find alternative routes through smaller veins that were never designed to handle that volume — causing them to swell dangerously.

The immune system weakens. The liver plays a central role in immune defence. A cirrhotic liver leaves the body significantly more vulnerable to serious infections.

Hormones go out of balance. A failing liver cannot break down hormones properly. In men, this can cause breast tissue growth and testicular shrinkage. In women, menstrual irregularities are common.

Not all cirrhosis is the same. It exists on a spectrum, and where someone sits on that spectrum makes a significant difference to their prognosis, their symptoms, and their treatment options.

Stage 1 and 2 — Compensated Cirrhosis

In the early stages, the liver is scarred but still managing. It is working overtime to compensate for what it has lost, and for most people, it is succeeding well enough that there are no obvious symptoms. Many people at this stage feel completely normal — which is both good news (the liver is coping) and a risk (the disease goes unnoticed and untreated).

People with compensated cirrhosis who receive appropriate treatment and make necessary lifestyle changes can remain stable for many years. Median survival at this stage is around 12 years — and many live considerably longer.

Stage 3 and 4 — Decompensated Cirrhosis

Decompensation is when the liver can no longer keep up. It crosses a threshold where it simply cannot maintain the body's basic needs — and complications begin to develop. The defining complications of decompensation are ascites (abdominal fluid), hepatic encephalopathy (brain fog and confusion), variceal bleeding (bleeding from swollen veins), and significant jaundice.

Once decompensation occurs, the situation becomes more serious and requires more intensive medical management. Without a liver transplant, median survival at this stage is two to five years — though good management significantly influences that timeline.

Doctors use two main scoring systems to measure severity. The Child-Pugh score grades the disease as A, B, or C based on five clinical parameters. The MELD score — calculated from blood test results — is the most widely used tool for determining transplant priority, with higher scores reflecting more urgent need.

One of the most challenging aspects of cirrhosis is that the early stages produce no symptoms at all. The liver is quietly scarring while the person feels perfectly fine — which is why so many cases are discovered incidentally on blood tests or scans done for completely different reasons.

When symptoms do begin, they tend to be vague and easy to dismiss.

Early symptoms include:

• Persistent tiredness that does not improve with rest
• Mild loss of appetite
• Nausea or feeling of fullness after small meals
• A dull ache or discomfort in the upper right abdomen
• Unintentional weight loss

As the disease progresses, more noticeable signs appear:

• Yellowing of the skin and eyes (jaundice)
• Visible abdominal swelling from fluid accumulation
• Spider-like blood vessel marks on the skin of the chest and shoulders
• Redness of the palms
• Significant muscle wasting, particularly in the arms and legs
• Itchy skin, especially in bile duct-related liver disease
• Swelling of the ankles and feet
• Confusion, difficulty concentrating, or personality changes

In men, breast tissue may develop and testicles may shrink. In women, periods may become irregular or stop.

The critical message is this — do not wait for symptoms before getting checked. If you have risk factors for liver disease, ask your doctor about screening. By the time symptoms appear, the disease has usually been present for years.

Cirrhosis of the liver does not have one single cause. It is the final common endpoint of many different liver diseases that all share one thing in common — they cause chronic, repeated liver cell injury that eventually leads to scarring.

Alcohol-related liver disease is one of the leading causes worldwide. Drinking heavily over many years — generally more than 14 units per week sustained over a long period — causes progressive liver damage. Not everyone who drinks heavily develops cirrhosis, because genetics influence individual susceptibility, but the risk rises considerably with the amount and duration of drinking. Alcohol-related cirrhosis is one of the most preventable forms of the disease.

Chronic hepatitis C causes cirrhosis in roughly 15 to 30 percent of people with untreated infection over 20 to 30 years. The virus triggers chronic inflammation that slowly replaces healthy liver tissue with scar tissue. The good news is that hepatitis C is now curable — a short course of modern antiviral tablets eliminates the virus in over 95 percent of patients and stops further liver damage.

Chronic hepatitis B drives cirrhosis through decades of viral-induced inflammation. Unlike hepatitis C, it cannot yet be cured — but it can be suppressed to undetectable levels with daily antiviral medication, halting the progression of liver damage.

Non-alcoholic steatohepatitis (NASH) — the inflammatory form of fatty liver disease — is now one of the fastest-growing causes of cirrhosis globally, driven by rising rates of obesity, type 2 diabetes, and sedentary lifestyles. It develops silently in people who drink little or no alcohol but whose liver accumulates fat and becomes inflamed over time.

Autoimmune hepatitis occurs when the body's immune system mistakenly attacks its own liver cells, causing chronic inflammation. Left untreated, it progresses to cirrhosis — but it responds well to immunosuppressive medication in most cases.

Bile duct diseases — including primary biliary cholangitis and primary sclerosing cholangitis — cause progressive bile duct damage, bile accumulation inside the liver, and fibrosis.

Inherited metabolic conditions such as haemochromatosis (excess iron), Wilson's disease (excess copper), and alpha-1 antitrypsin deficiency cause cirrhosis by depositing toxic substances in liver cells over decades.

Certain factors make cirrhosis more likely — either by increasing exposure to liver-damaging agents or by speeding up the rate at which fibrosis develops.

Heavy long-term alcohol use is the most significant modifiable risk factor. The combination of how much you drink and for how long determines your risk.

Untreated viral hepatitis — both B and C — drives progressive liver damage over decades. Many people do not know they are infected because both viruses can be completely silent for years.

Obesity and type 2 diabetes significantly increase the risk of NASH and NASH-related cirrhosis. Even modest excess weight raises risk meaningfully, and the risk climbs with BMI.

Having multiple liver risk factors simultaneously dramatically accelerates damage. Someone who drinks heavily and also has hepatitis C suffers far more rapid fibrosis than someone with either condition alone.

Male sex is consistently associated with faster fibrosis progression across most types of liver disease — a difference attributed partly to hormonal factors and partly to higher average alcohol consumption in men.

Older age at infection is associated with faster fibrosis development. A person who contracts hepatitis C at 50 will typically reach cirrhosis faster than someone infected at 25.

Genetic predisposition — specific gene variants that influence how the liver handles inflammation and fibrosis — affects individual susceptibility, which explains why some people develop cirrhosis despite modest risk factors while others remain unaffected despite decades of heavy drinking.

The complications of cirrhosis are where the disease becomes most dangerous — and most distressing for patients and families. Understanding them helps in recognising warning signs early and seeking prompt treatment.

Ascites is the most common complication — fluid accumulating in the abdominal cavity, causing the abdomen to swell visibly. It is uncomfortable, can restrict breathing, and creates the risk of a serious abdominal infection called spontaneous bacterial peritonitis (SBP).

Spontaneous bacterial peritonitis occurs when bacteria infect the fluid in the abdomen without any obvious external cause. It is potentially life-threatening and requires immediate antibiotic treatment. It happens because the cirrhotic liver cannot maintain adequate gut immune defences, allowing bacteria to cross from the intestine into the abdominal cavity.

Hepatic encephalopathy is brain dysfunction caused by toxin accumulation — particularly ammonia — that the failing liver cannot clear. Symptoms range from mild confusion and forgetfulness to severe disorientation, slurred speech, and coma. Episodes are often triggered by infections, bleeding, constipation, or missed medications.

Variceal bleeding is one of the most feared complications — and one of the most dangerous. As portal pressure rises, veins in the oesophagus and stomach engorge and become fragile. When they rupture, the bleeding can be massive and life-threatening, presenting as vomiting blood or passing black, tar-like stools. This is a medical emergency.

Hepatorenal syndrome is a serious deterioration of kidney function that develops in advanced cirrhosis. The kidneys essentially shut down in response to the circulatory changes caused by liver failure. Without a liver transplant, outcomes are very poor.

Liver cancer (hepatocellular carcinoma) develops in cirrhotic livers at a rate of one to five percent per year. This is why all patients with cirrhosis need regular surveillance — an ultrasound and blood test every six months — to catch cancer at a stage where it can still be treated.

Coagulopathy — impaired blood clotting from reduced clotting factor production — increases bleeding risk from any injury or procedure and complicates medical management.

Diagnosing cirrhosis involves putting together information from several different sources — no single test tells the complete story.

Blood tests are usually the starting point. Liver function tests measure bilirubin, albumin, and liver enzymes — all of which reflect how well the liver is working. A prolonged clotting time (INR) indicates that the liver is struggling to produce enough clotting factors. A low platelet count often reflects an enlarged spleen from portal hypertension. Kidney function tests monitor for early hepatorenal syndrome.

FibroScan is the most important non-invasive test for assessing liver scarring. It works by sending a gentle ultrasound pulse through the liver and measuring how stiff the tissue is — stiffer liver means more scarring. It takes about ten minutes, is completely painless, and has largely replaced liver biopsy for routine fibrosis assessment. Results are expressed in kilopascals, with higher values indicating more advanced disease.

Ultrasound scan examines the liver's size, shape, and surface texture. A cirrhotic liver often appears nodular and shrunken on ultrasound. The scan also assesses the spleen size, looks for ascites, and evaluates blood flow through the portal vein. It is the primary tool for regular liver cancer surveillance in patients with cirrhosis.

CT and MRI scans provide more detailed imaging when needed — particularly to investigate liver masses, assess blood vessel anatomy, or plan for surgery or transplantation.

Gastroscopy — a camera examination of the oesophagus and stomach — is performed at diagnosis to look for varices. Finding them determines whether preventive treatment with beta-blocker medication or endoscopic procedures is needed.

Liver biopsy — taking a tiny tissue sample from the liver for microscopic examination — remains the definitive way to confirm cirrhosis and identify its cause with certainty. Because it carries a small bleeding risk, it is now reserved for situations where non-invasive tests have not provided a clear enough picture.

Treatment for cirrhosis works on two levels at the same time — stopping further damage by addressing the underlying cause, and managing the complications that cirrhosis produces.

Stopping the underlying cause

This is always the first priority, because removing the source of ongoing damage gives the liver its best chance of stabilising.

For alcohol-related cirrhosis, complete and permanent abstinence from alcohol is the single most important step a patient can take. Even in patients with established cirrhosis, stopping alcohol can stabilise the disease and meaningfully extend life. Specialist addiction support, counselling, and medications that help maintain abstinence are all valuable tools here.

For hepatitis C, modern antiviral drugs cure the infection in over 95 percent of patients in eight to twelve weeks. Clearing the virus stops ongoing viral-driven inflammation, reduces the risk of liver cancer, and — in patients with compensated cirrhosis — can lead to genuine fibrosis reversal over time.

For hepatitis B, daily antiviral tablets suppress the virus to undetectable levels, stopping inflammation and cancer risk. Treatment is usually lifelong but is generally well tolerated.

For NASH, gradual weight loss of ten percent or more of body weight significantly reduces liver fat and inflammation and can reverse fibrosis in earlier-stage disease. Diet and regular physical activity are the primary tools — no medication yet matches the effectiveness of sustained weight loss.

Managing complications

Ascites is managed with a low-sodium diet and diuretic tablets — typically spironolactone with furosemide. When ascites become resistant to medication, a needle can be inserted to drain the fluid directly — a procedure called paracentesis. In some patients, a small internal shunt (TIPS procedure) reduces portal pressure and prevents fluid from re-accumulating.

Hepatic encephalopathy is treated with lactulose — a syrup that reduces ammonia production in the gut — and rifaximin, an antibiotic tablet that prevents the gut bacteria responsible for ammonia production from proliferating. Identifying and treating any trigger (infection, bleeding, dehydration) is equally important.

Variceal bleeding is treated urgently with endoscopic band ligation — placing tiny elastic bands around the varices during a gastroscopy procedure — and medications that reduce blood pressure in the portal vein. Prevention involves non-selective beta-blockers and regular endoscopic surveillance.

Spontaneous bacterial peritonitis is treated with intravenous antibiotics and albumin infusions. Long-term low-dose antibiotics prevent recurrence in high-risk patients.

Nutrition deserves special mention. Patients with cirrhosis are commonly malnourished and lose muscle mass rapidly. High-protein meals, frequent small snacks, and a late-evening carbohydrate snack are recommended to maintain muscle and energy stores. A specialist dietitian is an invaluable member of the care team.

Liver transplantation is the only treatment that can replace a failing liver entirely. It is considered when the disease reaches a point where medical management can no longer adequately control complications — typically when the MELD score rises to 15 or above, or when specific life-threatening complications develop. One-year survival after liver transplantation exceeds 85 to 90 percent at experienced centres, and many recipients go on to live full, normal lives.

For the most common causes of cirrhosis, the answer is largely yes — and the steps involved are practical and achievable.

Get vaccinated against hepatitis B. The hepatitis B vaccine is safe, highly effective, and available to everyone. It provides lifelong protection in most people and is one of the few cancer-prevention vaccines available — because hepatitis B causes both cirrhosis and liver cancer.

Get tested and treated for hepatitis C. A simple blood test identifies infection. Modern treatment cures it in weeks. People who received blood transfusions before 1992, have ever injected drugs, or have other risk factors should ask their doctor for a hepatitis C test — it could genuinely be lifesaving.

Drink alcohol within safe limits — or not at all. Keeping alcohol consumption low or eliminating it entirely is one of the most impactful things a person can do for long-term liver health. For anyone already diagnosed with liver disease, complete abstinence is the safest choice without exception.

Maintain a healthy weight. Even modest weight management significantly reduces the risk of NASH and NASH-related cirrhosis. Regular physical activity and a balanced diet protect the liver directly — not through any complex mechanism, but simply by reducing the fat and metabolic stress that drives fatty liver disease.

Manage diabetes and high cholesterol. Both conditions are linked to accelerated liver damage. Keeping blood sugar and cholesterol controlled reduces the metabolic burden on the liver.

Be cautious with supplements and herbal remedies. Many herbal products are a surprisingly common cause of drug-induced liver injury. Always tell your doctor about any supplements you are taking — and never assume that "natural" means safe for the liver.

Regular health checks matter. Routine blood tests that include liver function can pick up early liver disease years before cirrhosis develops — creating a window for intervention when the damage is still reversible.

The outlook for cirrhosis depends largely on when it is diagnosed and how effectively it is managed. People with compensated cirrhosis can often live for many years, especially when the underlying cause such as hepatitis C, alcohol use, or fatty liver disease is treated. In some cases, liver scarring may partially improve over time.

Even decompensated cirrhosis can be managed successfully with specialist care, helping patients maintain a good quality of life. For those with advanced disease, liver transplantation offers excellent long-term outcomes. The key message is clear: early diagnosis, timely treatment, and consistent medical follow-up significantly improve survival and overall health.